Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05064709 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of CCM in HF With Higher Ejection Fraction

Study acronym: AIM HIGHer
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 78 record versions are listed below. See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 1 of 105 sitesv78
  2. Re-verified, no change to tracked fieldsv77
  3. Trial sites reduced: 112 → 105 locationsv76
  4. Site details revised at 2 of 112 sitesv75
  5. Site details revised at 1 of 112 sitesv74
Show 45 earlier versionsHide 45 earlier versions
  1. Study sites: 109 to 112v73
  2. Study sites: 108 to 109v72
  3. Study sites: 105 to 108v71
  4. Primary and study completion dates: Feb 1, 2026 to Feb 1, 2029 Study sites: 104 to 105v70 Show 1 more changeShow less
    • Study sites: 104 to 105
  5. Site details revised at 2 of 104 sitesv69
  6. Study sites: 103 to 104v68
  7. Primary completion date: Feb 1, 2025 to Feb 1, 2026 Study sites: 102 to 103 · Eligibility criteria expanded, about 91 words · Study description revisedv67 Show 3 more changesShow less
    • Study sites: 102 to 103
    • Eligibility criteria expanded, about 91 words
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  8. Site details revised at 1 of 102 sitesv66
  9. Site details revised at 18 of 102 sitesv65
  10. Study sites: 101 to 102v64
  11. Study sites: 100 to 101v63
  12. Study sites: 99 to 100v62
  13. Study sites: 98 to 99v61
  14. Study sites: 97 to 98v60
  15. Study sites: 96 to 97v59
  16. Study sites: 95 to 96v58
  17. Study sites: 94 to 95v57
  18. Study sites: 91 to 94v56
  19. Study sites: 90 to 91v55
  20. Study sites: 89 to 90v54
  21. Study sites: 88 to 89v53
  22. Study sites: 87 to 88v52
  23. Study sites: 85 to 87v51
  24. Study sites: 84 to 85v50
  25. Study sites: 83 to 84v49
  26. Study sites: 82 to 83v48
  27. Study sites: 80 to 82v47
  28. Study sites: 79 to 80v46
  29. Study sites: 78 to 79v45
  30. Study sites: 74 to 78v44
  31. Study sites: 72 to 74v43
  32. Study sites: 69 to 72 Eligibility criteria expanded, about 64 wordsv42 Show 1 more changeShow less
    • Eligibility criteria expanded, about 64 words

    See this version in full on ClinicalTrials.gov ↗

  33. Study sites: 68 to 69v41
  34. Study sites: 66 to 68v40
  35. Study sites: 64 to 66v39
  36. Study sites: 63 to 64v38
  37. Study sites: 60 to 63v37
  38. Study sites: 59 to 60v36
  39. Study sites: 58 to 59v35
  40. Study sites: 57 to 58v34
  41. Study sites: 55 to 57v33
  42. Study sites: 54 to 55v32
  43. Study sites: 52 to 54v31
  44. Study sites: 51 to 52v30
  45. Study sites: 50 to 51v29
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
Trial Details
NCT Number NCT05064709
Lead Sponsor Impulse Dynamics
Conditions Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Heart Failure With Moderately Reduced Ejection Fraction, Diastolic Heart Failure
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov